Study of Antiviral Efficiency of Oxidized Dextrans In Vitro and In Vivo


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Antiviral efficiency of oxidized dextrans (OD) with different molecular weights and oxidation degree (OD40min, OD70min, OD40max, and OD70 max) was studied in vitro and in vivo. Dextrans OD40max and OD70max prevented the development of the cytopathic effect of influenza A(H1N1)pdm09 virus in more than 50% MDCK cells vs. control (no OD). Four intranasal doses of OD40min, OD40max, and OD70min and one intranasal dose of OD70max before infection of BALB/c mice with A(H1N1)pdm09 influenza virus significantly reduced mortality and prolonged life span in comparison with controls receiving saline. These and our previous data attest to clear-cut preventive effect of OD in influenza infection.

About the authors

O. G. Kurskaya

Research Institute of Experimental and Clinical Medicine

Author for correspondence.
Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

T. A. Murashkina

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

A. Yu. Alekseev

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

K. A. Sharshov

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

L. P. Romakh

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

A. A. Derko

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

A. V. Troitskii

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

T. N. Bystrova

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk

V. A. Shkurupy

Research Institute of Experimental and Clinical Medicine; Novosibirsk Medical University, Ministry of Health of the Russian Federation

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk; Novosibirsk

A. M. Shestopalov

Research Institute of Experimental and Clinical Medicine

Email: kurskaya_og@mail.ru
Russian Federation, Novosibirsk


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies